RC

Rajesh Chaitannyakumar Jain

Active Director Director DIN 09686569
DIN 09686569 First appointment Jul 2022 Primary industry Electrnoics
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Jul 2022
Shareholding value β€’β€’β€’β€’ Premium profile

About Rajesh Chaitannyakumar Jain

Data last updated:

Rajesh Chaitannyakumar Jain is a Director at Avexa Pharmaceuticals Private Limited (since 2022). The company operates in Electrnoics.

DIN 09686569
Primary Designation Director
Industry Electrnoics
First Appointment 26 Jul 2022
Oldest Company Age 4 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director26 Jul 20222022Active

Board colleagues of Rajesh Chaitannyakumar Jain

Directorship timeline

Open interactive timeline →
Avexa Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Rajesh Chaitannyakumar Jain

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Rajesh Chaitannyakumar Jain

Rajesh Chaitannyakumar Jain currently holds 1 directorship: Avexa Pharmaceuticals Private Limited (Director, since 26 Jul 2022).

Rajesh Chaitannyakumar Jain was first appointed on 26 Jul 2022 as Director at Avexa Pharmaceuticals Private Limited.

The current boards of Rajesh Chaitannyakumar Jain's companies include Manisha Kiran Utekar (Avexa Pharmaceuticals Private Limited), Milind Dashrath Gumphekar (Avexa Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available